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Cytotoxic effects were observed following 4 h incubation of human leukaemic cells with the iron chelator 
I-hydroxypyridine-2-thione (ornadine). Its cytotoxic activity was comparable to that of the cytotoxic drug 
doxorubicin. At the same concentration two other effective iron chelators, desferrioxamine and 1,2-di- 
methyl-3-hydroxypyrid-4-one, were not cytotoxic. Addition of iron augmented the effect of omadine. It is 
suggested that the lipophilic properties of omadine and of its iron complex cause their intracellular accumu- 
lation and potent cytotoxic activity. 
Omadine Chelator Iron 
1. INTRODUCTION 
Many iron requiring enzymes are involved in 
metabolic pathways essential for the growth and 
development of normal and malignant cells [ 1,2]. 
Under normal conditions iron is well confined and 
controlled by proteins and other molecules but if it 
is not strongly chelated it can be toxic [3]. Iron 
chelators by affecting intracellular and ex- 
tracellular iron transport and storage may inhibit 
DNA synthesis and other metabolic processes 
dependent on iron [2,4,5]. A direct effect on the 
iron-dependent enzyme ribonucleotide reductase 
has been shown in a cell free system [6], and has 
been postulated in the intact cell [7,8]. Effective 
iron chelators like desferrioxamine may inhibit the 
toxicity of iron in vitro, but less effective ones like 
EDTA may exacerbate its toxic effects [9,10]. 
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CytotoxicitJ Thymidine uptake 
Desferrioxamine has been reported to inhibit 
DNA synthesis in a variety of cell culture systems, 
although the effect has only been seen at high drug 
concentrations or with prolonged exposure of the 
cells to the drug [ 1 l-131. Other potential iron 
chelating drugs may be more effective in inhibiting 
DNA synthesis [7,11], and some have been 
reported to be cytotoxic [ 11,14,15]. 
Here we have assessed inhibition of DNA syn- 
thesis and cytotoxicity for human myeloid 
leukaemic cells of three iron chelators, namely 
desferrioxamine, 1,2-dimethyl-3-hydroxypyrid-4- 
one 121, 1 -hydroxypyridine-2-thione (ornadine) 
alone or with added iron and compared their effec- 
tiveness to that of the cytotoxic drug doxorubicin. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
Desferrioxamine was obtained from Ciba- 
Geigy, England, 1-hydroxypyridine-2-thione from 
Sigma, England, doxorubicin from Farmitalia 
Carlo Erba and 1,2-dimethyl-3-hydroxypyrid-4- 
one was prepared as described [2] based on a 
method of preparation of other pyridone 
derivatives [161. Chelators were dissolved in RPM1 
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1640 medium (Flow Labs, England) at 2 x 10T3 M; 
and appropriate dilutions were dispensed in 20 ~1 
triplicate aliquots in the wells of 96-well microtitre 
plates and the plates kept at 4°C and used within 
one month. Doxorubicin was freshly dissolved or 
stored at -20°C. In the cytotoxicity experiments 
in which FeCL (Sigma, London) was used, the iron 
was dissolved in RPM1 and preincubated with the 
chelators for 2 h at room temperature and subse- 
quently stored at 4°C for up to 5 days. 
2.2. Partition coefficients 
The n-octanol/water partition coefficients of the 
chelators were determined as follows: 4 ml drug 
(10m5 M) dissolved in PBS mixed for 5 min in the 
Whirley mixer with 4 ml n-octanol, the two layers 
allowed to separate and the mixture centrifuged 
for 5 min at 2200 x g. The absorbances of both the 
aqueous and n-octanol layers were measured at 
selected wavelengths of the UV region, in the 
vicinity of or at the h,,, of each chelator, by using 
an SP 1700 Unicam spectrophotometer. 
2.3. Red blood cell membrane permeability 
Fresh heparinised blood was collected from a 
normal donor; packed red cells were prepared by 
spinning for 5 min at 2200 x g and by removing 
the supernatant, white cells and the top layer of red 
cells containing the reticulocytes. The packed red 
cells were washed three times with PBS and spun 
for 5 min at 2200 x g each time. Chelator-iron 
mixtures were prepared by adding to each chelator 
(4 x 10m4 M final concentration) a solution of iron 
(lo-’ M final concentration) containing traces of 
s9Fe (59FeC13, Amersham, England). Equal 
volumes (750 al) of packed red cells were added to 
the chelator-iron mixture (0.2 &i 59Fe) in PBS and 
200 ~1 aliquots were withdrawn at 15 min and 1 h 
after mixing, spun for 3 min through 100 ~1 silicon 
oil (d = 1.05, Aldrich, Gillingham, England) in a 
micro-tube using a Beckman B microfuge, frozen 
in liquid nitrogen, cut and separated into a cell part 
(bottom) and a supernatant/oil part (top). The 
59Fe activity in the cell and the supernatant/oil 
parts of each sample were counted separately using 
an LKB-Wallac 1280 ultragamma counter. 
2.4. Cell cultures 
The human leukaemic myeloid cell lines U937, 
HL60 and ML2 were grown at 37°C in humidified 
atmosphere containing 7.5% CO2 and fed three 
times a week with RPM1 1640 medium containing 
10070 FCS, 2 mM L-glutamine, 100 U/ml penicillin 
and 100 pg/ml streptomycin. Cell concentration 
was kept between 0.8 and 2.5 x lo6 cells/ml and 
the cultures were always fed the day before each 
experiment to ensure exponential growth. Cell 
viability at the beginning of experiments was 
always >95% by the trypan blue exclusion 
method. Before each experiment cells were washed 
twice with RPM1 and resuspended in the same 
medium (with no FCS added) at a concentration 
0.25-l x lo6 cells/ml. The cell suspension was 
dispensed in 180~1 aliquots into the wells of 
96-well microtitre plates (flat bottom) containing 
20 ~1 of drug solution in RPM1 and incubated for 
4 h at 37°C in humidified atmosphere + 7.5% 
co2. For DNA synthesis studies 0.4&i of 
[3H]TdR (5 Ci/mmol, Amersham, TRA 120) were 
added to each well for the last 1 h incubation. At 
the end of the incubation period the plates were 
washed once with cold PBS and the radioactivity 
incorporated in the cells was measured by 
harvesting the cultures with a cell harvester 
(Skatron, Norway) and washing with distilled 
water and methanol. Only [3H]TdR which was in- 
corporated into DNA was measured. 
The effect of chelators on cell growth was also 
evaluated by washing the cells twice after 4 h of in- 
cubation with the drugs and prolonging the in- 
cubation in RPM1 + 10% FCS + antibiotics; 
counts of viable cells were performed daily by the 
trypan blue exclusion method. Inhibition of 
[3H]leucine incorporation into cellular proteins 
was also studied as described [24] using U937 and 
HL60 cells at 0.5 x 106/ml, incubation for 4 h with 
omadine or omadine iron and addition of 
[3H]leucine (1 &i per well) 20 h later. 
3. RESULTS AND DISCUSSION 
3.1. Partition coefficients and red cell membrane 
permeability 
The n-octanol/water partition coefficients of the 
chelators varied, omadine being more lipophilic 
(KpBT = 0.4) than the other two chelators (table 1). 
It is known that small neutral molecules or metal 
complexes of Spar > 0.3 can diffuse into matured 
red cells [2] which are not metabolically active on 
iron uptake and also possibly through other cell 
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study 74% of 59Fe from the 
omadine iron complex 
cells (assessed entry) 
15 min and 76% 1 h of incubation 
1,2-dimethyl-3-hydroxypyrid-4-one iron complex 
mixtures entered (table 1). data suggest hat 
omadine is a lipophilic chelator which abili- 
ty to rapidly transport 
across the red cell membrane. other 
two chelators, namely desferrioxamine which is 
charged and 
which is neutral but hydrophilic, 
plexes do not facilitate across 
the red cell membrane after 1 h of incubation 
(table 1) [2]. 
3.2. Inhibition of ceil growth 
Growth of U937 was substantially inhibited by 
4 h incubation with omadine which, at a concen- 
tration of 2 x lo-’ M, caused complete killing of 
the leukaemic cells within the first 24 h (fig.1). 
Similarly the incorporation of [3H]leucine into 
U937 and HL60 was also inhibited at the same con- 
centration (2 x10-’ M), and at lower concentra- 
tions (table 3). The addition of equimolar iron to 
omadine (2 x 10m6 M) enhanced its cytotoxicity at 
each time point (fig.1). Iron or desferrioxamine 
alone at the same concentrations and the addition 
of equimolar iron to desferrioxamine did not in- 
crease inhibition of DNA synthesis or cytotoxicity 
under the same experimental conditions (not 
shown). 
3.3. ,Inhibition of [3H]TdR uptake 
The effect of the chelators, at concentrations of 
2 x lo-’ M or lower, on [3H]TdR uptake in short- 
term culture varied between the three different cell 
lines studied (table 2). Inhibition of [3H]TdR up- 
take by omadine was higher in the HL60 and ML2 
cell lines than in U937. The degree of inhibition 
was comparable to that of the cytotoxic drug dox- 
orubicin which was more effective than omadine in 
U937, similar on HL60 and less effective on ML2. 
Desferrioxamine and 1,2-dimethyl-3-hydroxypy- 
rid+one had no effect at the concentrations 
studied. 
The cytotoxic and [3H]TdR cell uptake in- 
hibiting effects obtained with short-term exposure 
of the lipophilic chelator omadine or its iron com- 
plex suggests that its mechanism of action is a 
rapid accumulation and irreversible inhibition of 
an intracellular or membrane-associated compo- 
nent to which the chelator or a metal complex of 
the chelator can bind and react. A different 
mechanism of action can be postulated for the 
hydrophilic chelators since no significant cytotox- 
icity or DNA inhibition was obtained after short- 
term incubations (4 h) with desferrioxamine or 
with 1,2-dimethyl3-hydroxypyrid-4-one. The in- 
hibitory effects previously observed with desfer- 
rioxamine at high concentrations [ 1 l] or prolonged 
(16 h) incubations [12] may have been mediated 
through interactions with the cell membrane or ex- 
tracellularly through iron starvation. Alternatively 
these effects [11,12] may be due to a slow in- 
Table 1 
Physicochemical properties of the chelators 
Chelator 
Desferrioxamine 
1,2-Dimethyl-3- 
hydroxypyrid-4-one 
Omadine 
M Charge G., %Feb incorporation 
at pH 7.3 n-octanol/ 
water 15 min lh 
561 positive 0.02 4.0 5.0 
139 neutral 0.18 3.0 6.0 
127 neutral 
zwitterionic 0.40 74.0 76.0 
a Kpar is the partition coefficient of the chelators estimated in n-octanol/water at 
pH 7.3 
b The percentage incorporation of ‘9Fe into red blood cells in the presence of the 
chelators was estimated from the total s9Fe count of red blood cells plus 
supernatant/oil (100% “Fe, 1.4 x lo3 cpm) 
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24 48 72 96 
Time, Hours from Start of Experiment 
Fig. 1. The effect of chelators on cell growth. U937 cells 
(0.2 x lo6 cells/ml) were incubated for 4 h with the 
drugs, washed twice, and the incubation was prolonged 
in RPM1 1640 + 10% FCS. Viable cells were counted 
daily by the trypan blue exclusion method. (M) 
Control, (O---O) 2 x 10v5 M desferrioxamine, (M) 
2 x 10m5 M omadine, (H) 2 x 10m5 M omadine + 
2 x 10e5 M FeCls, (ti) 2 x 10m6 M omadine, 
(A--A) 2 x 10e6 M omadine + 2 x 10e6 M Fe& 
tracellular accumulation of this chelator, its iron 
complex, or its metabolites. 
The incubation of omadine with iron markedly 
increased its cytotoxic effects in contrast to the 
lipophilic spermidine catecholamide chelators 
which were also shown to be cytotoxic in culture 
but for which the effects are reversed by iron [14]. 
The difference may be related to the inability of 
the spermidine catecholamide chelator-iron com- 
plexes to diffuse across the cell membrane due to 
their larger size. 
The cytotoxic effects of iron chelators may be 
related to the subtraction of iron from proteins 
(e.g. ribonucleotide reductase) or from metabolic 
pathways involving iron. Our data, however, show 
that in contrast to the above belief, in the case of 
omadine the addition of iron, rather than decreas- 
ing, enhances its toxicity substantially. Further- 
more, in the case of desferrioxamine and of 
1,2-dimethyl-3-hydroxypyrid-4-one which was 
shown to remove iron from transferrin [17,18] and 
ferritin [ 191 in vitro and also from animals to levels 
similar to those caused by desferrioxamine [2,10], 
no cytotoxic or [3H]TdR cell uptake effects were 
caused. Albert [20] suggested that the antibacterial 
and antifungal activity of omadine may be due to 
the oxidative damage caused by its iron complex. 
This mechanism of toxic activity was also sug- 
gested to occur with doxorubicin [21] and 
bleomycin [22] and there is further evidence from 
fluorimetric studies on lymphocytes that direct 
DNA damage occurs within 2 h incubation with 
omadine alone or plus iron (in preparation). Our 
data are in agreement with this mechanism for the 
direct cytotoxic effect of omadine but we also sug- 
gest that the enhancement of its toxicity in the 
presence of iron is due to the increased membrane 
permeability of the complex which is neutral at 
physiological pH in contrast to the chelator alone 
Table 2 
The IC50a of chelators on the [3H]thymidine uptake by U937, HL60 and 
ML2 cell lines 
Chelator u937 HL60 ML2 
Desferrioxamine >2 x 10-5M >2 x 10-5M >2 x 10-5M 
1,2-Dimethyl-3- 
hydroxypyrid-+one >2x 10-5M >2x lo-‘M >2x 10-5M 
Omadine >2 x 1O-5 M 5 x 1O-6 M lo-’ M 
Doxorubicin 1O-6 M lO-‘j M >2 x 1O-5 M 
a ICSO is the chelator concentration causing 50% inhibition of (3H]thymidine 
incorporation in the cells following 4 h incubation, in comparison to non- 
chelator treated cells (100070 13H]thymidine uptake: U937, 15x lo3 
cpm/106 cells; HL60, 37.1 x IO3 cpm/106 cells; ML2,75 x lo3 cpm/106 
cells) 
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Table 3 
Inhibition of [‘Hlleucine incorporation into U937 and 
HL60 by omadine and omadine iron 
Chelator 
concen- 
tration 
(M) 
[‘H]Leucine incorporation, 070” 
u937 HL60 
No added Added No added Added 
iron iron iron iron 
2 x 1o-5 7.7 1.3 1.7 0.5 
2 x 1o-6 58.3 50.9 3.1 1.2 
2 x lo-’ 80.5 87.9 - - 
a Percent of control (U937, 22.3 x lo3 cpm/106 cells; 
HLGO, 26.7 x lo3 cpm/106 cells) 
The results are the mean of three experiments. In the 
incubations with iron both omadine and iron were added 
at the same concentrations 
which is charged (zwitterionic). 
Omadine is a known fungicide commonly used 
in the cosmetic industry as a component of sham- 
poos and deodorants and has considerable low tox- 
icity in animals [23]. The subcutaneous or in- 
tragastric administration of omadine (270 mg/kg) 
to 15 and 5 mice, respectively, for 3 days caused no 
apparent ill-effects (unpublished). Its low animal 
toxicity and its high in vitro cytotoxic activity 
which is comparable to doxorubicin demand its 
further investigation as an anticancer agent. 
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